Literature DB >> 24421392

c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.

Duarte M S Ferreira1, Marta B Afonso, Pedro M Rodrigues, André L Simão, Diane M Pereira, Pedro M Borralho, Cecília M P Rodrigues, Rui E Castro.   

Abstract

MicroRNAs (miRs) are increasingly associated with metabolic liver diseases. We have shown that ursodeoxycholic acid, a hydrophilic bile acid, counteracts the miR-34a/sirtuin 1 (SIRT1)/p53 pathway, activated in the liver of nonalcoholic steatohepatitis (NASH) patients. In contrast, hydrophobic bile acids, particularly deoxycholic acid (DCA), activate apoptosis and are increased in NASH. We evaluated whether DCA-induced apoptosis of rat hepatocytes occurs via miR-34a-dependent pathways and whether they connect with c-Jun N-terminal kinase (JNK) induction. DCA enhanced miR-34a/SIRT1/p53 proapoptotic signaling in a dose- and time-dependent manner. In turn, miR-34a inhibition and SIRT1 overexpression significantly rescued targeting of the miR-34a pathway and apoptosis by DCA. In addition, p53 overexpression activated the miR-34a/SIRT1/p53 pathway, further induced by DCA. DCA increased p53 expression as well as p53 transcriptional activation of PUMA and miR-34a itself, providing a functional mechanism for miR-34a activation. JNK1 and c-Jun were shown to be major targets of DCA, upstream of p53, in engaging the miR-34a pathway and apoptosis. Finally, activation of this JNK1/miR-34a proapoptotic circuit was also shown to occur in vivo in the rat liver. These results suggest that the JNK1/p53/miR-34a/SIRT1 pathway may represent an attractive pharmacological target for the development of new drugs to arrest metabolism- and apoptosis-related liver pathologies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24421392      PMCID: PMC3958031          DOI: 10.1128/MCB.00420-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

1.  Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Authors:  Shu-Hao Hsu; Bo Wang; Janaiah Kota; Jianhua Yu; Stefan Costinean; Huban Kutay; Lianbo Yu; Shoumei Bai; Krista La Perle; Raghu R Chivukula; Hsiaoyin Mao; Min Wei; K Reed Clark; Jerry R Mendell; Michael A Caligiuri; Samson T Jacob; Joshua T Mendell; Kalpana Ghoshal
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

2.  A cytoplasmic inhibitor of the JNK signal transduction pathway.

Authors:  M Dickens; J S Rogers; J Cavanagh; A Raitano; Z Xia; J R Halpern; M E Greenberg; C L Sawyers; R J Davis
Journal:  Science       Date:  1997-08-01       Impact factor: 47.728

3.  Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.

Authors:  Rui E Castro; Joana D Amaral; Susana Solá; Betsy T Kren; Clifford J Steer; Cecília M P Rodrigues
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-04-12       Impact factor: 4.052

4.  c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration.

Authors:  Robert F Schwabe; Cynthia A Bradham; Tetsuya Uehara; Etsuro Hatano; Brydon L Bennett; Robert Schoonhoven; David A Brenner
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  Deoxycholic and chenodeoxycholic bile acids induce apoptosis via oxidative stress in human colon adenocarcinoma cells.

Authors:  Juan Ignacio Barrasa; Nieves Olmo; Pablo Pérez-Ramos; Angélica Santiago-Gómez; Emilio Lecona; Javier Turnay; M Antonia Lizarbe
Journal:  Apoptosis       Date:  2011-10       Impact factor: 4.677

6.  Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation.

Authors:  C M Rodrigues; X Ma; C Linehan-Stieers; G Fan; B T Kren; C J Steer
Journal:  Cell Death Differ       Date:  1999-09       Impact factor: 15.828

7.  Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes.

Authors:  Susana Sola; Xiaoming Ma; Rui E Castro; Betsy T Kren; Clifford J Steer; Cecilia M P Rodrigues
Journal:  J Biol Chem       Date:  2003-09-26       Impact factor: 5.157

8.  Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.

Authors:  Paulo S Ribeiro; Helena Cortez-Pinto; Susana Solá; Rui E Castro; Rita M Ramalho; Amélia Baptista; Miguel C Moura; Maria E Camilo; Cecília M P Rodrigues
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

9.  Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1.

Authors:  Hajime Higuchi; Annette Grambihler; Ali Canbay; Steven F Bronk; Gregory J Gores
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

Review 10.  Role of miR-122 and lipid metabolism in HCV infection.

Authors:  Takasuke Fukuhara; Yoshiharu Matsuura
Journal:  J Gastroenterol       Date:  2012-09-11       Impact factor: 7.527

View more
  34 in total

1.  What it means to receive the UEG Rising Star Award.

Authors: 
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

2.  Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis.

Authors:  André L Simão; Marta B Afonso; Pedro M Rodrigues; Margarida Gama-Carvalho; Mariana V Machado; Helena Cortez-Pinto; Cecília M P Rodrigues; Rui E Castro
Journal:  J Mol Med (Berl)       Date:  2019-05-28       Impact factor: 4.599

3.  Celastrol ameliorates acute liver injury through modulation of PPARα.

Authors:  Qi Zhao; Ping Tang; Ting Zhang; Jian-Feng Huang; Xue-Rong Xiao; Wei-Feng Zhu; Frank J Gonzalez; Fei Li
Journal:  Biochem Pharmacol       Date:  2020-05-26       Impact factor: 5.858

4.  Galectin-3 regulates inflammasome activation in cholestatic liver injury.

Authors:  Jijing Tian; Guoxiang Yang; Huan-Yuan Chen; Daniel K Hsu; Alexey Tomilov; Kristin A Olson; Ali Dehnad; Sarah R Fish; Gino Cortopassi; Bin Zhao; Fu-Tong Liu; M Eric Gershwin; Natalie J Török; Joy X Jiang
Journal:  FASEB J       Date:  2016-09-14       Impact factor: 5.191

5.  Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.

Authors:  Supriya R Kulkarni; Carol J Soroka; Lee R Hagey; James L Boyer
Journal:  Hepatology       Date:  2016-10-28       Impact factor: 17.425

Review 6.  Emergence of miR-34a in radiation therapy.

Authors:  Jerome Lacombe; Frederic Zenhausern
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-01       Impact factor: 6.312

Review 7.  MicroRNAs in injury and repair.

Authors:  Cory V Gerlach; Vishal S Vaidya
Journal:  Arch Toxicol       Date:  2017-05-13       Impact factor: 5.153

Review 8.  Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target.

Authors:  Yuting Wu; Xiaoming Meng; Cheng Huang; Jun Li
Journal:  Tumour Biol       Date:  2015-05-01

9.  Deoxycholic acid modulates cell death signaling through changes in mitochondrial membrane properties.

Authors:  Tânia Sousa; Rui E Castro; Sandra N Pinto; Ana Coutinho; Susana D Lucas; Rui Moreira; Cecília M P Rodrigues; Manuel Prieto; Fábio Fernandes
Journal:  J Lipid Res       Date:  2015-09-08       Impact factor: 5.922

Review 10.  Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.

Authors:  Manoela Mota; Bubu A Banini; Sophie C Cazanave; Arun J Sanyal
Journal:  Metabolism       Date:  2016-03-03       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.